Skip to main content

Post-IPO Equity Therapeutics Companies

Explore 204 therapeutics startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
204
Total Funding
$1.8B
Avg Funding
$70.9M
Cities
21

Export 204 Post-IPO Equity Therapeutics Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Copenhagen, Denmark
$6.6M
raised

IO Biotech is a clinical-stage biotech company developing disruptive immune therapies for the treatment of cancer.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$21.0M
raised

Synlogic is a biotechnology company that develops synthetic biotic medicines to perform metabolic functions to treat diseases.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lexington, United States
$60.0M
raised

Fractyl Health is a biotechnology company that provides curative therapies for metabolic diseases.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wilmette, United States
$135.0M
raised

Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$27.0M
raised

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

Sep 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Redwood City, United States
$150.0M
raised

Allakos is a biotechnology company developing therapeutic antibodies targeting allergy, inflammatory and proliferative diseases.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

$3.8M
raised

Mydecine Innovations Group is a biotechnology company that develops a novel therapeutics to treat mental health and addiction disorders.

Sep 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Indianapolis, United States
$125.0M
raised

Point Biopharma focused on the development and commercialization of radioligand therapies for the treatment of cancer.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$20.0M
raised

Codiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.

Sep 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$690.0M
raised

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Sep 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Loma Linda, United States
$1.2M
raised

Aditxt Therapeutics is a biotechnology company that develops a novel nucleic acid-based technology.

Aug 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Beverly, United States
$12.0M
raised

BioVie specializes in the development of innovative solutions for the treatment of neurodegenerative and liver diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Diego, United States
$25.0M
raised

Poseida Therapeutics is a biopharmaceutical company utilizing gene engineering capabilities to develop targeted therapeutics.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Malvern, United States
$1.9M
raised

Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New Haven, United States

Arvinas advances therapies degrading disease-causing proteins for life-threatening diseases, from discovery to commercialization.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Dublin, Ireland
$2.2M
raised

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$5.0M
raised

Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Woburn, United States
$4.1M
raised

Comera Life Sciences Holdings is an engineering superior biotherapeutic formulations for fragile patients.

Aug 2023
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$120.0M
raised

Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.

Aug 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cincinnati, United States
$225.0M
raised

CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.

Aug 2022
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 204 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Culver City, United States
$80.0M
raised

ImmunityBio is a late-stage immunotherapy startup that is developing treatments to drive immunogenic pathways in the fight against cancer.

Jul 2025
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Alameda, United States
$7.5M
raised

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$15.0M
raised

Elicio Therapeutics is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$12.0M
raised

Checkpoint Therapeutics is an immuno-oncology biopharmaceutical company specializing in cancer therapy development.

Jul 2024
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New York, United States
$23.5M
raised

DarioHealth is a digital therapeutics company engaged in the development and commercialization of patented and proprietary technology.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 204 companies

Ready to Connect with Post-IPO Equity Therapeutics Startups?

Get verified founder emails, funding details, and company data for 204 post-ipo equity therapeutics companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked